"Mupirocin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.
| Descriptor ID |
D016712
|
| MeSH Number(s) |
D02.355.291.411.658 D03.383.663.555 D10.251.536
|
| Concept/Terms |
Mupirocin- Mupirocin
- Pseudomonic Acid A
- Pseudomonic Acid
- Acid, Pseudomonic
|
Below are MeSH descriptors whose meaning is more general than "Mupirocin".
Below are MeSH descriptors whose meaning is more specific than "Mupirocin".
This graph shows the total number of publications written about "Mupirocin" by people in this website by year, and whether "Mupirocin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 3 | 0 | 3 |
| 2019 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mupirocin" by people in Profiles.
-
Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical Trial. JAMA. 2023 10 10; 330(14):1337-1347.
-
Delineating the Impact of Mupirocin and Chlorhexidine Gluconate in Intensive Care Units-Models and Real-Life Considerations. JAMA Netw Open. 2021 03 01; 4(3):e211573.
-
Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial. Lancet. 2019 Mar 23; 393(10177):1205-1215.
-
Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers. N Engl J Med. 2019 02 14; 380(7):638-650.
-
Decreased Hospital Costs and Surgical Site Infection Incidence With a Universal Decolonization Protocol in Primary Total Joint Arthroplasty. J Arthroplasty. 2017 03; 32(3):728-734.e1.
-
Chlorhexidine and Mupirocin Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates in the REDUCE-MRSA Trial. J Clin Microbiol. 2016 11; 54(11):2735-2742.
-
Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Screening and Decolonization to Reduce Surgical Site Infection in Elective Total Joint Arthroplasty. J Arthroplasty. 2016 09; 31(9 Suppl):144-7.
-
Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: an analysis of a cluster-randomised trial. Lancet Infect Dis. 2016 Jan; 16(1):70-79.
-
Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013 Jun 13; 368(24):2255-65.
-
Chlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents. Antimicrob Agents Chemother. 2013 Jan; 57(1):552-8.